Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 305-314 , April 2010

Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: A review of human studies

References 

  1. Belkind-Gerson J, Carreón-Rodríguez A, Contreras-Ochoa CO, Estrada- Mondaca S, Parra-Cabrera MS. Fatty acids and neurodevelopment. J. Pediatr. Gastroenterol. Nutr. 2008;47:S7–S9
  2. Innis SM. Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35–43
  3. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992;120:S129–S138
  4. Dobbing J, Sands J. Quantitative growth and development of human brain. Arch. Dis. Child. 1973;48:757–767
  5. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 1980;4:121–129
  6. Koletzko B, Larque E, Demmelmair H. Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA). J. Perinat. Med. 2007;35:S5–S11
  7. Vaidyanathan VV, Rao KV, Sastry PS. Regulation of diacylglycerol kinase in rat brain membranes by docosahexaenoic acid. Neurosci. Lett. 1994;179:171–174
  8. Poling JS, Karanian JW, Salem N, Vicini S. Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid. Mol. Pharmacol. 1995;47:381–390
  9. Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J. Neurochem. 1996;66:1582–1591
  10. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids. 1996;31(Suppl.):S193–S197
  11. Chalon S, Delion-Vancassel S, Belzung C, et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 1998;128:2512–2519
  12. Simmer K, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst. Rev. 2004;1:
  13. SanGiovanni JP, Parra-Cabrera S, Colditz GA, Berkey CS, Dwyer JT. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics. 2000;105:1292–1298
  14. Clandinin MT, Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formula containing docosahexaenoic acid and arachidonic acid. J. Pediatr. 2005;146:461–468
  15. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcome of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301:175–182
  16. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2001;4:CD000376
  17. SanGiovanni JP, Berker CS, Dwyer JT, Colditz GA. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infant: a systematic review. Early Hum. Dev. 2000;57:165–188
  18. Hoffman DR, Boettcher JA, Diersen-Schade DA. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids. 2009;81:151–158
  19. Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot. Essent. Fatty Acids. 2007;76:189–203
  20. Innis SM, Vaghri Z, King DJ. n-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am. J. Clin. Nutr. 2004;80:768–773
  21. Levitt P. Structural and functional maturation of the developing primate brain. J. Pediatr. 2003;143:335–345
  22. Chugani HT. A critical period of brain development: studies of cerebral glucose utilization with PET. Prev. Med. 1998;27:184–188
  23. Oyster CW. The Human Eye–Structure and Function. Sunderland, MA: Sinauer Associates Inc.; 1999;
  24. Lien VW, Clandinin MT. Dietary assessment of arachidonic acid and docosahexaenoic acid intake in 4-7 year-old children. J. Am. Coll. Nutr. 2009;28:7–15
  25. Institute of Medicine . Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC: National Academy Press; 2002;
  26. Kris-Etherton PM, Innis S. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J. Am. Diet. Assoc. 2007;107:1599–1611
  27. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosapentaenoic acids. J. Nutr. 2009;139:804S–819S
  28. Scientific Advisory Committee on Nutrition . The Nutritional Wellbeing of the British Population. Norwich, UK: The Stationary Office; 2008;
  29. European Food Safety Authority, Draft scientific opinion of the Panel of Dietetic Products, Nutrition and Allergies on a request from the European Commission related to dietary reference values for fats, EFSA J. 1–97, in press.
  30. Madden SMM, Gerrioch CF, Holub BJ. Direct diet quantification indicates low intakes of (n-3) fatty acids in children 4 to 8 years old. J. Nutr. 2009;139:1–5
  31. Sichert-Hellert W, Wicher M, Kersting M. Age and time trends in fish consumption patterns of children and adolescents, and consequences for the intake of long-chain n-3 polyunsaturated fatty acids. Eur. J. Clin. Nutr. 2009;63:1071–1075
  32. United States Department of Agriculture, 1994–96 Continuing Survey of Food Intakes by Individuals and Diet and Health Knowledge Survey, Accessed June 2009, Available at: 〈http://www.barc.usda.gov/bhnrc/foodsurvey/home.htm〉.
  33. Bakker EC, Ghys AJA, Kester ADM, et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 years of age. Eur. J. Clin. Nutr. 2003;57:89–95
  34. Ghys A, Bakker E, Hornstra G, van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum. Dev. 2002;69:83–90
  35. Bakker EC, Hornstra G, Blanco CE, Vles JSH. Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur. J. Clin. Nutr. 2009;63:499–504
  36. Touwen BCL. Examination of the Child with Minor Neurological Dysfunction. London: Spastics International Medical Publications; 1979;
  37. Zhang J, Hebert JR, Muldoon MF. Dietary fat intake is associated with psychosocial and cognitive functioning of school-aged children in the United States. J. Nutr. 2005;135:1967–1973
  38. Whalley LJ, Fox HC, Wahle KW, Starr JM, Deary IJ. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am. J. Clin. Nutr. 2004;80:1650–1657
  39. Aberg MA, Aberg N, Brisman J, Sundberg R, Winkvist A, Toren K. Fish intake of Swedish male adolescents is a predictor of cognitive performance. Acta Paediatr. 2009;98:555–560
  40. Cohen JT, Bellinger DC, Connor WE, Shaywitz BA. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am. J. Prev. Med. 2005;29:366–374
  41. Hibbeln JR, Davis JN, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC): an observational study. Lancet. 2007;369:578–585
  42. Oken E, Radesky JS, Wright RO, et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am. J. Epidemiol. 2008;167:1171–1181
  43. Oken E, Østerdal ML, Gillman MW, et al. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am. J. Clin. Nutr. 2008;88:789–796
  44. Budtz-Jorgensen E, Grandjean P, Weihe P. Separation of risks and benefits of seafood intake. Environ. Health Perspect. 2007;115:323–327
  45. US Department of Health and Human Services, What you need to know about mercury in fish and shellfish, March 2004. Internet: http://www.cfsan.fda.gov/∼dms/admehg3.html, accessed 10 November 2009.
  46. Koletzko B, Cetin I, Brenna JT. Dietary fat intake for pregnant and lactating women. Br. J. Nutr. 2008;36:5–14
  47. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111:e39–e44
  48. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child. Fetal Neonatal Ed. 2008;93:F45–F50
  49. The Nemo Study Group . Effect of a 12-Mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebo-controlled studies in Australia and Indonesia. Am. J. Clin. Nutr. 2007;86:1082–1093
  50. Walker SP, Wachs TD, Gardner JM, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet. 2007;369:145–157
  51. Muthayya S, Eilander A, Transler C, et al. Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children’s Health and Mental Performance Influenced by Optimal Nutrition) Study. Am. J. Clin. Nutr. 2009;89:1–10
  52. Ryan AS, Nelson EB. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin. Pediatr. 2008;47:355–362
  53. Bailey-Hall E, Nelson EB, Ryan AS. Validation of a rapid measure of blood PUFA levels in humans. Lipids. 2008;43:181–186
  54. Arterburn LM, Bailey Hall E, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids. Am. J. Clin. Nutr. 2006;83:1467S–1476S
  55. Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts CM. A randomized control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot. Essent. Fatty Acids. 2009;80:143–149
  56. R.K. McNamara, J. Able, M.P.R. Jandacek, et al., Docosahexaenoic acid supplementation augments prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled dose ranging fMRI study, Am. J. Clin. Nutr., doi:10.3945/ajcn.2009.28549
  57. Kennedy DO, Jackson PA, Elliot JM, et al. Cognitive and mood effects of 8 weeks’ supplementation with 400mg or 1000mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10–12 years. Nutr. Neurosci. 2009;12:48–56
  58. Yannicelli S, Ryan AS. Improvements in behavior and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine restricted diet: a national survey. J. Inherit. Metab. Dis. 1995;18:131–134
  59. Giovannini B, Biasucci G, Agostoni C, Luotti D, Riva E. Lipid status and fatty acid metabolism in phenylketonuria. J. Inherit. Metab. Dis. 1995;18:265–272
  60. Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur. J. Pediatr. 1996;155(suppl):S33–S38
  61. Stemerdink BA, Kalverboer AF, van der Meere JJ, et al. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J. Inherit. Metab. Dis. 2000;23:548–562
  62. Agostoni C, Massetto N, Biasucci G, et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J. Pediatr. 2000;137:504–509
  63. Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology. 2001;57:1488–1491
  64. Koletzko B, Beblo S, Demmelmair H, Hanebutt FL. Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU). J. Pediatr. Gastroenterol. Nutr. 2009;48:S2–S7
  65. Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J. Pediatr. 2007;150:479–484
  66. Stevens L, Zhang W, Peck L, et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive disorders. Lipids. 2003;38:1007–1021
  67. Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioral symptoms of attention deficit hyperactivity disorder in adolescents: a case–control study. Nutr. J. 2008;7:8
  68. Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid comparison in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 1996;26:35–46
  69. P. Montgomery, A.J. Richardson, Omega-3 fatty acids for bipolar disorder, Cochrane Database Syst. Rev. 2008, Issue 2, Art. no. CD005169.
  70. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomized double-blind placebo-controlled study. Br. J. Psychiatry. 2006;75:315–321
  71. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder. Arch. Gen. Psychiatry. 1999;56:407–412
  72. Freeman MP, Hibbeln JR, Wisner KL, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J. Clin. Psychiatry. 2006;67:1954–1967
  73. Bekaroglu M, Asian Y, Gedik Y. Relationship between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J. Child. Psychol. Psychiatry. 1996;37:225–227
  74. Voigt RG, Llorente AM, Jensen CL, Frayley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 2001;139:189–196
  75. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002;26:233–239
  76. Richardson AJ, Montgomery P. The Oxford-Durham Study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115:1360–1366
  77. Lin P-Y, Su K-P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry. 2007;68:1056–1061
  78. Raz R, Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev. Med. Child. Neurol. 2009;51:580–592

PII: S0952-3278(10)00051-7

doi: 10.1016/j.plefa.2010.02.007

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 305-314 , April 2010

Article Tools